Empowering appropriate antimicrobial use with rapid diagnostics.

OUR MISSION

The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner with rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.

1.0_TTT_dividerbar_440

LATEST NEWS

0_TTT_news_A_140

World Health Organization (WHO) Global Report on Antibiotic Resistance

The report reveals that this serious threat is no longer a prediction for the future; it is happening right now in every region of the world… Read More


0_TTT_news_B_140

Do health plans have a role in limiting antibiotic resistance?

The CDC calls antibiotic resistance the world’s most pressing public health threat… Read More



0_TTT_news_C_140

Molecular Flu Results in less than
15 Minutes

Alere™ i Influenza A & B is the first and only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes on the user-friendly Alere™ i platform.… Read More

RAPID DIAGNOSTIC TESTING

A comprehensive set of diagnotic information, empowering a shift  in prescribing behavior away from the over-use of antibiotics.

1.0_TTT_dividerbar_440
Contact

DO YOU HAVE QUESTIONS?

Contact us today to find out more about the Test Target Treat™ initiative and how rapid diagnostics will benefit your patients.